Jesús María González-Zapatero

Jesús María González-Zapatero

Auto-generated profile, based on publicly available information

Jesús María González-Zapatero

Complejo Asistencial Universitario de Salamanca. Servicio de Otorrinolaringología y Cirugía de Cabeza y Cuello. Salamanca. España

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Revista ORL
Verified
Journal Article
Open access
PDF file
JGJesús María González-Zapatero
Jesús María González-Zapatero
MFMaría José Fernández-Nava
María José Fernández-Nava
SFSofía Ferreira-Cendón
Sofía Ferreira-Cendón
EGEnrique González-Sánchez
Enrique González-Sánchez
JSJosé Manuel Serradilla-López
José Manuel Serradilla-López
ÁCÁngel Batuecas Caletrio
Ángel Batuecas Caletrio
Introduction and objective: Meniere's disease (MD) is a chronic auditory pathology characterized by the presence of hearing loss, episodic dizziness and tinnitus. The objective of this studie is to value the hearing improvement and the reduction of vertiginous crises in patients with Meniere acute accent s disease after the administration of intratympanic corticosteroids (ITS). Method: Retrospective cohort study of a sample of 55 patients diagnosed with definitive Meniere's disease and treated with intratympanic corticosteroids. Results: Of the 39 patients who were treated with ITS for vertigo attacks, one month into the treatment, 27 had no attacks, 11 experienced a few ( 10). There were 16 patients treated with ITS for hearing loss and they reflected a mean hearing loss of 46.61 dB prior to the treatment. One month after the injection, the mean loss was 42.77 dB (1.84) and at six months it was 41.66 dB (2.95). Discussion: The audiometric benefit obtained is approximate to 3 dB und a clear decrease in the number of vertiginous crises after ITS, other authors in their studies have obtained results similar to ours. Conclusions: Our results show that intratympanic corticosteroids is an effective therapy for the control of vertiginous crises and hearing loss.